72496-41-4 Usage
Description
Pirarubicin is a new anthracycline anticancer agent structurally related to doxorubicin. In
acute leukemia, non-Hodgkin’s lymphoma, breast and ovariail carcinoma, pirarubicin is
reportedly superior to doxorubicin and better tolerated. Its major side-effect appears to be
myelosuppression, mainly in the form of leucopenia, which is potentially dose-limiting.
Chemical Properties
Red Solid
Uses
Different sources of media describe the Uses of 72496-41-4 differently. You can refer to the following data:
1. Structural analog of Doxorubicin. Antineoplastic.
2. Structural analog of Doxorubicin. Antineoplastic
Brand name
Pinorubicin; Therarubucin
Check Digit Verification of cas no
The CAS Registry Mumber 72496-41-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,4,9 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 72496-41:
(7*7)+(6*2)+(5*4)+(4*9)+(3*6)+(2*4)+(1*1)=144
144 % 10 = 4
So 72496-41-4 is a valid CAS Registry Number.
InChI:InChI=1/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19?,21+,22-,31+,32-/m0/s1